NOTE: This order is nonprecedential United States Court of Appeals for the Federal Circuit BAYER HEALTHCARE PHARMACEUTICALS INC. AND BAYER SCHERING PHARMA AG, Plaintiffs-Appellees, V. WATSON PHARMACEUTICALS, INC. AND WATSON LABORATORIES, INC., Defendants-Appellants, AND SANDOZ INC., Defendant-Appellant.

2012-1397, -1398, -1400 Appeals from the United States District Court for the District of Nevada in consolidated case nos. O7-CV-1472 and 08-CV-0995, Judge Kent J. Dawson.

BAYER SCHERING PHARMA AG AND BAYER HEALTHCARE PHARMACEUTICALS, INC., Plaintiffs-Appellees, BAYER HEALTHCARE PHARMA V. WATSON PHARMA 2 V. LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants 2012-1424 Appeal from the United States District Court for the District of Nevada in case no. 10-CV-1166, Judge Kent J.

Dawson.

ON MOTION Before LOURIE, Circuit Judge.

ORDER Upon consideration of Sandoz lnc., Watson Pharma- ceuticals, Inc., Watson Laboratories, lnc., Lupin Ltd., and Lupin Pharmaceuticals, Inc.’s unopposed motion to con- solidate appeal 2012-1397 et a1. with appeal 2012-1424, and for additional words in the parties' briefs, IT ls ORDERED THAT: The motion to consolidate the appeals is granted The appellants' opening brief is due no later than July 16, 2012. The motion to increase the word count for the briefs is denied. The revised official caption is reflected above.

3 BAYER HEALTHCARE PHARMA V. WATSON PHARMA FoR THE CoURT 2 Z[]lz /s/ Jan Horbaly Date J an Horbaly Clerk cc: Peter B. Bensinger, Jr., Esq.

Robert Fritz Green, Esq.

Joseph A. Hynds, Esq.

Mark T. Jansen, Esq.

826 u.s counfi)"z`§\ln=)z=m\s son msrensrmclncun JUL 02 2012 . JAN HURBALY CLERK